| 标题 |
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of The American Academy of Dermatology 作者:Brett Hughes; Alexander Guminski; Samantha Bowyer; Michael R. Migden; Chrysalyne D. Schmults; et al 出版日期:2024-09-07 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)